VGX Pharmaceuticals, LLC Report issue

For profit Phase 1 Phase 2
Founded: Blue Bell PA United States (2000)
Status: Acquired by Inovio Pharmaceuticals (2009) → now AstraZeneca (2015)

Organization Overview

First Clinical Trial
2005
NCT00255177
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree